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Anabolic androgenic steroids (AAS) are among the drugs most used by athletes for improving physical performance, as well as for aesthetic
purposes. A number of papers have showed the side effects of AAS in different organs and tissues. For example, AAS are known to suppress
gonadotropin-releasing hormone, luteinizing hormone, and follicle-stimulating hormone. This study investigates the effects of nandrolone
on testosterone biosynthesis in Leydig cells using various methods, including mass spectrometry, western blotting, confocal microscopy
and quantitative real-time PCR. The results obtained show that testosterone levels increase at a 3.9mM concentration of nandrolone and
return to the basal level a 15.6mM dose of nandrolone. Nandrolone-induced testosterone increment was associated with upregulation of
the steroidogenic acute regulatory protein (StAR) and downregulation of 17a-hydroxylase/17, 20 lyase (CYP17A1). Instead, a 15.6mM
dose of nandrolone induced a down-regulation of CYP17A1. Further in vivo studies based on these data are needed to better understand
the relationship between disturbed testosterone homeostasis and reproductive system impairment in male subjects.
J. Cell. Physiol. 231: 1385–1391, 2016.  2015 The Authors. Journal of Cellular Physiology Published by Wiley Periodicals, Inc.
Anabolic androgenic steroids (AAS) are probably the most
commonly used drugs among athletes for improving physical
performance (Gheshlaghi et al., 2015; Piacentino et al., 2015).
The use of AAS was forbidden by the International Olympic
Committee in 1976, and the World Anti-Doping Agency has
included these compounds in the list of prohibited substances
(Hartgens and Kuipers, 2004). Despite these bans, AAS
consumption is constantly increasing particularly among the
younger population at ﬁtness centers (Hartgens and Kuipers,
2004), as well as among teenagers, also for aesthetic purposes
(McPhail et al., 2014). Hence, the abuse of AAS is nowadays
considered amajor andwidespread public health issue (Basaria,
2010).
Athletes usually take AAS in the form of intramuscular
injections and it has been estimated that AAS abusers
consume 600–5000mg of AAS per week; this is 10–100
times more than the normal testosterone production level
by testes (Fronczak et al., 2012). Such dosage may cause
serious health consequences especially on male fertility,
such as the suppression of the spermatogenesis, testicular
atrophy, gynecomastia, and virilization (Basaria, 2010;
Chimento et al., 2012; Fronczak et al., 2012). The use of
synthetic testosterone and cognate substances leads to a
reduction in natural testosterone production, mostly due to
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a disturbance of the feedback in the hypothalamic–
pituitary-gonadal axis, with consequent decrease in its levels
in circulation (Kostic et al., 2011; Rahnema et al., 2014).
AAS disturb the endogenous production of gonadotrophins
and androgens, which can in turn affect the ultrastructure of
the testes (Naraghi et al., 2010; Rahnema et al., 2014). This
effect may persist for a long time after drug withdrawal
(Keeney et al., 1990). Moreover, there are clear evidence of
other serious side effects of AAS administration, that
include increased chance of heart attacks, mood changes,
liver cancer, and premature arrest of bone growth in
younger males (Bhasin et al., 2006; Basaria, 2010; Bhasin,
2010; Turillazzi et al., 2011; Pope et al., 2014).
Nandrolone is considered to be one of the most commonly
abused AAS worldwide (Shahidi, 2001; Hartgens and Kuipers,
2004). It has a structure very similar to testosterone and it is
included in the class II of AAS which includes 19-nor-
testosterone-derivates. Its properties include boosting tissue-
building, maintenance of strength and muscle mass, libido, and
bone health. Endogenous nandrolone is produced as a
byproduct during biochemical transformational reactions,
and its main metabolite (norandrosterone) can be detected
in human urine samples in a concentration range of
0.01–0.14mg/l (Reznik et al., 2001; Bjelic et al., 2014).
Despite the beneﬁcial effects of nandrolone and its use in the
treatment of many clinical conditions (Wood, 2004),
nandrolone administration to male rats induced spermatogenic
cell apoptosis (Shokri et al., 2010). Nevertheless, the
mechanisms underlying nandrolone-induced testicular toxicity
are not yet fully understood.
Testosterone, like other androgens, is produced within the
testis by specialized steroidogenic cells known as Leydig cells
(Kostic et al., 2011). The production of this hormone is
regulated by a complex neuroendocrine mechanism which
involves the pulsatile release of luteinizing hormone (LH) and
subsequent cAMP activation of a steroidogenic cascade.
Numerous steroidogenic stimuli, as well as intratesticular
factors, play a role in the intricate regulatory network of
testosterone (Wu et al., 2007; De Maddalena et al., 2012; Janjic
et al., 2012). Cholesterol is the common substrate for all types
of steroid hormone biosynthesis (including the testosterone
one) which begins in the cytosol and is completed in the
mitochondria. Steroidogenic acute regulatory protein (StAR)
transfers cholesterol to the inner membrane of mitochondria
and, through the mobilization and delivery from the outer to
the innermitochondrial membrane, cholesterol is converted to
pregnenolone by the cytochrome P450, family 11, subfamily A,
polypeptide 1 (CYP11A1) (Stocco et al., 2005). Pregnenolone
is further metabolized to progesterone by mitochondrial or
microsomal hydroxy-delta-5-steroid dehydrogenase, 3 beta-,
and steroid delta-isomerase 1 (HSD3B1). In Leydig cells,
maturation of progesterone to androstenedione is catalyzed by
the 17a-hydroxylase/17, 20 lyase (CYP17A1); further, the
conversion of androstenedione to testosterone is dependent
on the activity of 17b-hydroxysteroid dehydrogenase, a steroid
dehydrogenase speciﬁc for androgen production (Kostic et al.,
2011; Macaluso et al., 2013).
The aim of this study was to investigate the effects of
nandrolone on testosterone production by Leydig cells, by
evaluating levels, and expression of the main enzymes involved
in testosterone biosynthesis.
Materials and Methods
Cell cultures
R2C cells (cat. No. 89031606, ECACC, Health Protection Agency
Culture Collections, Salisbury, United Kingdom), a rat Leydig cell
line used for testing the steroidogenic function, were cultured in
M-199 medium (Invitrogen Corp., Carlsbad, CA) supplemented
with 15% horse serum (HS; Invitrogen Corp.), 2.5% fetal bovine
serum (FBS; Invitrogen Corp.), and an antibiotic and antimycotic
solution (Invitrogen Corp.) containing 100U/ml penicillin,
100mg/ml streptomycin, 0.25mg/ml amphotericin B. Cells were
incubated at 37°C in a humidiﬁed atmosphere with 5% CO2, and
maintained in culture as previously described (Macaluso et al.,
2012; Barone et al., 2013). When cells reached approximately 80%
conﬂuence, they were treated for 48 h with different
concentrations of nandrolone prepared by ﬁrst dissolving
Nandrolone Vetranal analytical standard (Sigma–Aldrich, St. Louis,
MO) in absolute ethanol to obtain a working solution, and then in
the culture medium without horse serum to reach the desired
concentrations (0–15.6mM).
Cell viability test
3-[4,5-Dimethylthiaoly]-2,5-diphenyltetrazolium bromide
(MTT) assay was conducted to detect cell proliferation. A total
of 5 103 cells per well were seeded in 96-well plates, and
after the incubation period of 24 and 48 h with serial dilutions
of nandrolone working solution (0–500mM), fresh MTT
solution (100ml), dissolved in PBS (0.5 mg/ml ﬁnal
concentration), was added to the cells. After 3 h of incubation
at 37°C, the culture media were discarded and replaced with
100ml of Dimethyl Sulfoxide. Absorbance was measured at
570 nm in a spectrophotometer. The colorimetric assay was
performed in triplicate. Absorbance of untreated cells (basal)
was considered 100%.
Liquid chromatography-mass spectrometry
Testosterone measurements were performed by “Locorotondo
Labs S.r.l.,” Palermo, Italy. Testosterone in the cell culture
medium was quantiﬁed using a validated method for serum/
plasma analysis of testosterone by liquid chromatography-mass
spectrometry (LC-MS/MS). The method, developed by
Chromsystems1, was fully validated on a AB Sciex API 5500
QTrapTM in terms of recovery (between 95% and 104%),
linearity (0.01–6.00mg/L), CV percentage for intra-assay (2.6%),
and CV percentage for inter-assay (5.2%) in serum. The
apparatus employed consists of an HPLC Eksigent ultra LC
110-XL System, coupled with a AB Sciex API 5500 QTrapTM
mass spectrometer equipped with a TurboIonSpray1 Ion
Source, working in positive ion mode. The scan Mode used was
Multiple Ion Monitoring (MRM) following the characteristic
transition 289.1!96.9 (quantiﬁer ion) and 289.1!109.0
(qualiﬁer ion) for Testosterone and 292.2!96.9 (quantiﬁer ion)
and 292.2!109.0 (qualiﬁer ion) for the Internal Standard
(Testosterone d3). MS parameters, optimized in order to
achieve an improved sensitivity, were the following: Curtain gas
(CUR): 20 a.u.; Ion Spray Voltage (IS): 5500 V; Ion Source Gas 1
(GS1): 40 a.u.; Ion Source Gas 2 (GS2): 40 a.u.; Temperature
(TEM): 650°C; Declustering Potential (DP): 90 for Testosterone
and Testosterone d3; Entrance Potential (EP): 8 for
Testosterone and 11 for Testosterone d9; Collision Energy (CE):
25 and 29 for the product ion 96.0 and 109.0 respectively, both
for Testosterone and for Testosterone d3; Collision Exit
Potential (CXP): 10 for Testosterone and Testosterone d3.
Chromatographic elution was performed on a reversed phase
column. Prior to be injected into the HPLC system, the samples
were subjected to a complex process of extraction, puriﬁcation,
and concentration. This sample pre-treatment included the use
of a reversed phase SPE plate (Solid Phase Extraction) that
enabled an adequate degree of sensitivity even when analysing a
complex matrix. Testosterone levels were also assayed in the
culture medium alone as blank, and the value obtained was under
the detection limit. Total testosterone analysis in cell cultures
was performed in quadruplicate in four different independent
experiments.
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Western blotting analyses
Western blotting was performed as previously described (Barone
et al., 2013). Equal amounts of proteins (40mg) were separated on
SDS–PAGE and transferred onto a nitrocellulose membrane
(BioRad, Segrate, Italy). After blocking with 5% albumin bovine
serum (Sigma–Aldrich), membranes were probed with primary
antibodies [rabbit anti-CYP17A1 (M-80) clone polyclonal
antibody, goat anti-HSD3B1 (P-18) clone polyclonal antibody,
rabbit anti-StAR (FL-285) clone polyclonal antibody, rabbit
anti-CYP11A1 (H-165) clone polyclonal antibody, and mouse
anti-b Actin C-4 clone monoclonal antibody, Santa Cruz
Biotechnology] diluted at 1:1000 overnight at 4°C. Protein bands
were visualized using the enhanced chemiluminescence (ECL)
detection system (GE Healthcare Life Sciences, Milan, Italy), the
protein levels were normalized for b actin and the data were
evaluated and quantiﬁed using ImageJ Free software (NIH,
Bethesda, MD). Each experiment was performed in triplicate.
Confocal analyses
Immunoﬂuorescence was performed as described previously
(Gorska et al., 2013). Cells were ﬁxed in ice-cold methanol,
incubated with unmasking solution (10mM trisodium citrate,
0.05% Tween-20) for 10min, and treated with blocking solution
(3% BSA in PBS) for 30min at 24°C. Then, a primary antibody
against CYP17A1 and StAR (Santa Cruz Biotechnology) was added
and incubated in a humidiﬁed chamber overnight at 4°C, diluted
1:100. Cells were incubated for 1 h at RT with a conjugated
secondary antibody (anti-rabbit IgG–FITC antibody produced in
goat, Sigma–Aldrich, 1:200 dilution); followed by 15min incubation
with HOECHT33342 (Sigma–Aldrich) diluted 1:1000. Finally,
slides were mounted with cover slips, and images were taken
immediately with a Leica Confocal Microscope TCS SP8 (Leica
Microsystems, Heidelberg, Germany). The confocal microscopy
analysis was carried out using the Leica application suite advanced
ﬂuorescences software. The staining intensity was measured as the
mean pixel intensity (PI) normalized to the CSA (cross-sectional
area) of all cells in ﬁve ﬁelds per slide. Each experiment was
quadrupled.
Quantitative real-time PCR (qRT-PCR)
The qRT-PCR technique was performed as previously described
(Barone et al., 2013; Di Felice et al., 2013). Total cellular RNA was
isolated from cell cultures using TRIzol1 REAGENT (Sigma–
Aldrich), according to the manufacturer’s instructions. RNA was
retro-transcribed using the ImProm-II Reverse Transcriptase Kit
(Promega Corporation, Madison, WI) to obtain cDNA, which was
ampliﬁed using the StepOnePlusTM Real-Time PCR System (Life
Technologies, Monza, Italy). qRT-PCR analysis was performed
using GoTaq qPCR Master Mix (A6001, Promega). The mRNA
levels were normalized to the levels obtained for hypoxanthine
phosphoribosyltransferase 1 (HPRT1), for beta-glucuronidase
(GUSB) and for Glyceraldehyde 3-phosphate dehydrogenase
(GADPH). Changes in the transcript level were calculated using
the 2-DDCT method (Livak and Schmittgen, 2001). The cDNA was
ampliﬁed using the primers shown in Table 1. cDNA was ampliﬁed
using the Rotor-geneTM 6000 Real-Time PCR Machine (Qiagen
GmbH, Germany). Each experiment was performed in triplicate.
TABLE 1. Forward and reverse primers used for qPCR
Primer Forward Reverse
GUSB 50-ACCACCCCTACCACCTATATC-30 50-ATCCAGTAGTTCACCAGCCC-30
HPRT1 50-TGTCATGAAGGAGATGGGAG-30 50-ATCCAGCAGGTCAGCAAAG-30
GAPDH 50-GAAACCCATCACCATCTTCC-30 50-TCCACGACATACTCAGCAC-30
CYP17A1 50-TGATCCAAAACTGACCGCC-30 50-TCCACCAGATTTCTGTCGCC-30
STAR 50-CCTTGGGCATACTCAACAAC-30 50-GCACCACCTTACTTAGCAC-30
Fig. 1. Effects of nandrolone on R2C cell viability. Effects of
treatment of R2C cells with different nandrolone doses (0–500mM)
for 48h evaluated by MTT cell viability tests. Vertical axis:
percentage of cell viability. Horizontal axis: nandrolone
concentration, in mM. Basal: untreated cells. Data are presented as
the mean  SD of triplicate experiments.
Fig. 2. Testosterone production. Testosterone production in cells
treated with 3.9 and 15.6mM nandrolone concentrations for 48h.
Vertical axis: testosterone levels (ng/ml). Horizontal axis:
nandrolone concentration, in mM. Basal: untreated cells. Data are
presented as the meanSD of quadruplicate experiments.
 ¼P< 0.001.
JOURNAL OF CELLULAR PHYSIOLOGY
N A N D R O L O N E A N D T E S T O S T E R O N E B I O S Y N T H E S I S 1387
Statistical analyses
A one-way ANOVA followed by a Bonferroni post-hoc test for
multiple comparisons was used as an appropriate analysis for the
data. All statistical analyses were performed using the GraphPad
PrismTM 4.0 program (GraphPad Software Inc., San Diego,
California). All data are presented as the mean SD, and the level
of statistical signiﬁcance was set at P< 0.05.
Results
Cell viability
The inhibitory effect of nandrolone on R2C cell growth was
evaluated using MTT cell viability assays. The cells were
treated with serial dilutions of nandrolone within the range of
0–500mM, for 24 and 48 h. After 24 h of treatment,
nandrolone did not induce signiﬁcant cell death, while cell
viability was affected by 48 h of nandrolone treatment at
various concentrations. Figure 1 shows the mean value of cell
viability after nandrolone treatment. To evaluate the effects
of different nandrolone concentrations without signiﬁcant
cell death, 3.9 and 15.6mM of nandrolone were used for 48 h
for further experiments.
Testosterone production
To determine testosterone secretion, the medium was
collected at the end of the incubation period and subsequently
analyzed. The nandrolone working solution induced, after 48 h,
an increase of the secreted testosterone in R2C cells treated
with 3.9mM nandrolone, compared to the basal sample
(P< 0.05) (Fig. 2). Interestingly, a higher concentration
(15.6mM) did not induce a signiﬁcant testosterone increment
compared to basal values.
Levels of enzymes involved in testosterone synthesis
Lysates of R2C cells treated with different nandrolone
concentrations were analyzed by western blotting analyses to
verify the effects of nandrolone stimulation on the levels of
proteins involved in testosterone synthesis. Our results
showed that levels of StAR (Fig. 3) increased signiﬁcantly in
R2C cells treated with 3.9mM nandrolone compared to both
basal and 15.6mM (P< 0.05). These results were conﬁrmed by
confocal analyses (Fig. 4A and C). Interestingly, the levels of
CYP17A1 decreased upon treatment with 15.6mM of
nandrolone compared to both basal and 3.9mM (P< 0.05)
(Fig. 3). In addition, these results were in agreement with
confocal analyses (Fig. 4B and D). Finally, western blotting
analyses for CYP11A1 andHSD3B1 protein levels did not show
any signiﬁcant differences between untreated and treated cells
(Fig. 3), and this datum was also in accordance with confocal
analyses (not shown).
Expression of StAR and CYP17A1 genes
In order to elucidate nandrolone-induced modiﬁcation of the
levels of StAR and CYP17A1, qRT-PCR analyses were
performed for both molecules. The results showed that
changes in both protein levels were related to variation in gene
expression, as showed in Figure 5. In particular, expression of
StARmRNA increased signiﬁcantly (Fig. 5A) while expression of
CYP17A1mRNAdecreased signiﬁcantly (Fig. 5B) in cells treated
with both 3.9 and 15.6mM concentrations of nandrolone,
compared to basal levels (P< 0.05).
Discussion
In many countries, the attention towards performance-
enhancing drug use has focused on elite athletes and the illicit
Fig. 3. Effect of nandrolone stimulation on steroidogenic proteins. (A) Representative cropped blots for StAR (30 kDa), CYP11A1 (60 kDa),
HSD3B1 (42 kDa), and CYP17A1 (55 kDa). The gels were run under the same experimental conditions and b-actin was used as internal
control. (B) Relative expression levels of StAR, CYP11A1, HSD3B1, and CYP17A1. Vertical axis: arbitrary units (AU). Horizontal axis:
nandrolone concentration, in mM. Basal: untreated. Data are presented as the meanSD of triplicate experiments.  ¼P< 0.05.
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competitive advantage gained from these drugs (Pope et al.,
2014). However, performance-enhancing drugs are also used
by many non-athletes not only for enhancing performance, but
also their personal appearance. Moreover, there is widespread
misperception on the safety of performance-enhancing drug
use or on the manageability of the adverse effects, when in fact
these adverse effects still need to be better clariﬁed (Pope
et al., 2012). AAS is a category of performance-enhancing drugs
widely used to enhance muscular mass, which are also used for
the treatment of many clinical conditions (Pope et al., 2014).
In this study, we investigated the effects of nandrolone on
the main enzymes involved in testosterone biosynthesis in
Leydig cells. Testosterone is mainly produced by the Leydig
cells of the testes in males and by the theca cells of the ovaries
in females, although smaller amounts are synthesized by the
adrenal gland in both sexes (Kostic et al., 2011). Testosterone
plays a signiﬁcant role in the growth and development of the
male reproductive organs and it is generally accepted that AAS
exert their effects via androgen receptor (Hyypp€a et al., 1997).
The present study demonstrates that nandrolone
administration interferes with the biosynthesis of testosterone
in a dose-dependent fashion. The results showed a signiﬁcant
increase of testosterone levels in the culture medium of R2C
cells treated with 3.9mM of nandrolone, while the levels of this
hormone did not change at higher doses (15.6mM) of
nandrolone, compared to basal condition. To the best of our
knowledge, the present article is the ﬁrst to describe the effects
of nandrolone treatment on testosterone biosynthesis in
Leydig cells, and our results reinforce the data available in the
current literature on the deleterious effects of nandrolone
on testis.
Recently, it was demonstrated that nandrolone decaonate,
at the dose of 10mg/kg/week for 8 weeks, induced a decrease
of serum testosterone levels, a reduction of testicular weight,
and an alteration of sperm characteristics in rats (Ahmed,
2015). Nandrolone administration in rats determines a number
of morphological changes, such as reduction of the number and
the size of Leydig cells, cytoplasmic vacuolization, and lipid
droplet deposition. Moreover, from a biochemical point of
view, it induces testicular damage by triggering oxidative stress,
inﬂammatory cytokines, matrix metalloproteinases, cell-
adhesion molecules, apoptotic markers, and DNA damage
(Nagata et al., 1999; Noorafshan et al., 2005; Naraghi et al.,
2010; Ahmed, 2015; Bjelic et al., 2015).
In our experimental model, the most important data
obtained show that testosterone increases when Leydig cells
are stimulated with a lower concentration of nandrolone
(3.9mM), but this increment disappears when the cells are
treated with higher concentrations (15.6mM). These changes
are accompanied bymodiﬁcation at either protein or gene level
of some of the main factors involved in testosterone
production, such as StAR and CYP17A1. The latter data
suggests that nandrolone is able to interfere with testosterone
biosynthesis. Interestingly, we reported some discrepancies
between protein and gene levels in certain conditions. These
differences could be due to a number of causes (including
miRNA regulations, post-translational modiﬁcations, protein
degradation etc.) that are currently under investigation.
However, the presence of these discrepancies could indicate
that alternative (and probably unknown) routes for
testosterone biosynthesis are stimulated by nandrolone, and
should be further investigated in future studies.
Fig. 4. Effect of nandrolone supplementation on StAR and CYP17A1 levels: confocal analyses. (A and B) Representative microphotographs of
immunofluorescence stain for StAR (A) and CYP17A1 (B) in cells treated with 3.9 and 15.6mM of nandrolone. Basal: untreated cells.
Bar¼ 25mm. (C and D) Representative histograms of the immunofluorescence quantification of the staining intensity for StAR (C) and
CYP17A1 (D). The stain intensity was expressed as the mean pixel intensity (PI) normalized to the cross-sectional area (CSA) using the Leica
application suite advanced fluorescence software. Vertical axis: PI/CSA 100. Horizontal axis: nandrolone concentration, in mM. Data are
presented as the meanSD of quadruplicate experiments.  ¼P< 0.001.
JOURNAL OF CELLULAR PHYSIOLOGY
N A N D R O L O N E A N D T E S T O S T E R O N E B I O S Y N T H E S I S 1389
In conclusion, our results support the hypothesis that
nandrolone is able to modify testosterone production by
interfering with StAR and CYP17A1 expression in Leydig cells.
Further investigations are essential to better understand in
vitro the molecular mechanisms responsible of these changes.
Moreover, the data presented here also needs to be conﬁrmed
in in vivo models, in order to understand the relationship
between AAS administration and testis impairment in human
subjects.
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